Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
69.045,67
0,75%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Phathom Pharmaceuticals Inc (PHAT) Phathom Pharmaceuticals Inc (PHAT) Notizie

Phathom Pharmaceuticals Inc

PHAT
10,50
0,20 (1,94%)
25 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/5/202401:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202422:03EDGAR2Form 8-K - Current report
15/5/202414:00GLOBEPhathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan)..
09/5/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202414:05EDGAR2Form 8-K - Current report
09/5/202414:00GLOBEPhathom Pharmaceuticals Reports First Quarter 2024 Financial..
29/4/202414:00GLOBEPhathom Pharmaceuticals to Report First Quarter 2024..
03/4/202414:00GLOBEPhathom Pharmaceuticals to Participate in the 23rd Annual..
26/3/202413:00GLOBEPhathom Pharmaceuticals Launches Direct-to-Consumer..
07/3/202422:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202414:06EDGAR2Form 8-K - Current report
07/3/202414:00GLOBEPhathom Pharmaceuticals Reports Fourth Quarter and Full Year..
29/2/202414:00GLOBEPhathom Pharmaceuticals to Report Fourth Quarter and Full..
13/2/202414:05EDGAR2Form 8-K - Current report
13/2/202414:00GLOBEPhathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan)..
31/1/202414:00GLOBEPhathom Pharmaceuticals to Present at the Guggenheim..
23/1/202402:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202322:05EDGAR2Form 8-K - Current report
14/12/202314:05EDGAR2Form 8-K - Current report
14/12/202314:00GLOBEPhathom Pharmaceuticals Announces Expansion of Existing Loan..
06/12/202314:05EDGAR2Form 8-K - Current report
06/12/202314:00GLOBEPhathom Pharmaceuticals Announces FDA Acceptance for Filing..
28/11/202314:06EDGAR2Form 8-K - Current report
28/11/202314:00GLOBEPhathom Pharmaceuticals Announces Commercial Availability of..
20/11/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
09/11/202322:02EDGAR2Form S-3 - Registration statement under Securities Act of..
09/11/202314:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202314:05EDGAR2Form 8-K - Current report
09/11/202314:00GLOBEPhathom Pharmaceuticals Reports Third Quarter 2023 Results..
09/11/202301:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202321:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202322:50DJNPhathom Pharmaceuticals Gets FDA Approval for Voquezna..
01/11/202322:06EDGAR2Form 8-K - Current report
01/11/202322:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of VOQUEZNA®..
30/10/202313:05EDGAR2Form 8-K - Current report
30/10/202313:00GLOBEPhathom Pharmaceuticals Announces FDA Approval of..
25/10/202314:01GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
26/9/202314:05EDGAR2Form 8-K - Current report
26/9/202314:01GLOBEPhathom Pharmaceuticals Announces Vonoprazan NDA Submission..
05/9/202314:00GLOBEPhathom Pharmaceuticals to Participate in Upcoming Investor..
21/8/202314:07EDGAR2Form 8-K - Current report
21/8/202314:00GLOBEPhathom Pharmaceuticals Announces Submission of Six-Month..
10/8/202322:02EDGAR2Form 8-K - Current report
10/8/202314:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202314:01GLOBEPhathom Pharmaceuticals Reports Second Quarter 2023 Results
17/7/202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202322:04EDGAR2Form 8-K - Current report
17/7/202322:02EDGAR2Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
12/6/202315:04DJNFDA Accepts Phathom Pharmaceuticals' Resubmission for..
12/6/202314:01GLOBEPhathom Pharmaceuticals Announces FDA Acceptance of NDA..
Apertura: 10,40 Min: 10,0479 Max: 10,58
Chiusura: 10,30

La tua Cronologia

NASDAQ
PHAT
Phathom Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network